SEC Form 4 · accession 0001232524-18-000061
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Treacy
Officer — SVP, Technical Operations
Period of report
Mar 6, 2018
Accepted (ET)
Mar 7, 2018 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 6, 2018 | S | 594 | $141.465 | D | 18,641 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.